Morgan Stanley analyst Meta Marshall raised the firm’s price target on Axon (AXON) to $885 from $695 and keeps an Overweight rating on the shares. Morgan Stanley sees greater opportunities for drone proliferation with regulatory hurdles beginning to clear, the analyst tells investors in a research note. The firm sees Axon as the biggest near-term beneficiary in public safety and OT security.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AXON:
- Axon initiated with an Outperform at Wolfe Research
- Strategic Positioning and Growth Opportunities for Axon Enterprise in the Expanding Drone Market
- Axon Enterprise: Strong Market Position and Growth Potential with Innovative Public Safety Solutions
- Axon price target raised to $895 from $750 at BofA
- QQQ ETF News, 6/4/2025